The Effects of Metreleptin in Congenital Leptin Deficiency

计划入组 2 人 · 首次发布于 2019 年 8 月 21 日

Clinical Evaluation of Polyherbal Coded Formulation Obesecure for Leptin Regulation and Obesity Management

计划入组 132 人 · 首次发布于 2020 年 6 月 23 日

Setmelanotide for the Treatment of Leptin Receptor (LEPR) Deficiency Obesity

计划入组 15 人 · 首次发布于 2017 年 9 月 19 日

Leptin

Metreleptin(Myalept, Myalepta)

leptin mimetics (Lilly)

Rockwell Medical

United States

Ai-Media Technologies Ltd

United States

Nectin Therapeutics Ltd.

Israel

FDA Expands Setmelanotide Approval to Include Children Aged 2-5 with Rare Obesity Forms

MeiraGTx Receives FDA Breakthrough Therapy Designation for Gene Therapy Treating Radiation-Induced Dry Mouth

Chiesi Global Rare Diseases Highlights Advancements in Lipodystrophy Research at ENDO 2026